Behold.ai is an FDA- and CE-cleared AI radiology platform built around its proprietary red dot® technology, which analyzes chest X-rays and CT scans to detect critical conditions such as lung cancer and acute intracranial hemorrhage in near real time. Its two core products are red dot® CXR, which automatically identifies normal chest X-rays and triages suspected lung cancer cases for faster clinical decision-making, and red dot® CTH, which enables 24/7 triage of CT head scans to rule out normal exams and flag acute findings. The platform integrates directly with existing PACS and RIS systems regardless of vendor, and has been clinically validated across more than 32,000 patients with zero missed lung cancers over three years. It is designed for NHS trusts and hospital radiology departments, and has been deployed at institutions including Calderdale and Huddersfield NHS Foundation Trust, where it reduced suspected lung cancer waiting times by 71%. Pricing is subscription-based and custom-quoted through sales, with the company previously citing costs up to 50% lower than outsourced radiology reporting.
Leave a Reply